Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405.

Article  CAS  PubMed  Google Scholar 

Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36:1720–48.

Article  PubMed  PubMed Central  Google Scholar 

Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, Miller CB, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med. 2009;360:470–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Den Boer ML, van Slegtenhorst M, De Menezes RX, Cheok MH, Buijs-Gladdines JG, Peters ST, et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol. 2009;10:125–34.

Article  Google Scholar 

Roberts KG, Li Y, Payne-Turner D, Harvey RC, Yang YL, Pei D, et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014;371:1005–15.

Article  PubMed  PubMed Central  Google Scholar 

Mullighan CG. The genomic landscape of acute lymphoblastic leukemia in children and young adults. Hematol Am Soc Hematol Educ Program. 2014;2014:174–80.

Article  Google Scholar 

Roberts KG, Gu Z, Payne-Turner D, McCastlain K, Harvey RC, Chen IM, et al. High frequency and poor outcome of Philadelphia chromosome-like acute lymphoblastic leukemia in adults. J Clin Oncol. 2017;35:394–401.

Article  PubMed  Google Scholar 

Reshmi SC, Harvey RC, Roberts KG, Stonerock E, Smith A, Jenkins H, et al. Targetable kinase gene fusions in high-risk B-ALL: a study from the Children’s Oncology Group. Blood. 2017;129:3352–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ofran Y, Izraeli S. BCR-ABL (Ph)-like acute leukemia-pathogenesis, diagnosis and therapeutic options. Blood Rev. 2017;31:11–6.

Article  CAS  PubMed  Google Scholar 

Jain N, Roberts KG, Jabbour E, Patel K, Eterovic AK, Chen K, et al. Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults. Blood. 2017;129:572–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Herold T, Schneider S, Metzeler KH, Neumann M, Hartmann L, Roberts KG, et al. Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis. Haematologica. 2017;102:130–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heatley SL, Sadras T, Kok CH, Nievergall E, Quek K, Dang P, et al. High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment. Haematologica. 2017;102:e490–e3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wells J, Jain N, Konopleva M. Philadelphia chromosome-like acute lymphoblastic leukemia: progress in a new cancer subtype. Clin Adv Hematol Oncol. 2017;15:554–61.

PubMed  Google Scholar 

Tasian SK, Loh ML, Hunger SP. Philadelphia chromosome-like acute lymphoblastic leukemia. Blood. 2017;130:2064–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roberts KG, Reshmi SC, Harvey RC, Chen IM, Patel K, Stonerock E, et al. Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children’s Oncology Group. Blood. 2018;132:815–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chiaretti S, Messina M, Grammatico S, Piciocchi A, Fedullo AL, Di Giacomo F, et al. Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications. Br J Haematol. 2018;181:642–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siegele BJ, Nardi V. Laboratory testing in BCR-ABL1-like (Philadelphia-like) B-lymphoblastic leukemia/lymphoma. Am J Hematol. 2018;93:971–7.

Article  PubMed  Google Scholar 

Chiaretti S, Messina M, Foa R. BCR/ABL1-like acute lymphoblastic leukemia: how to diagnose and treat? Cancer. 2019;125:194–204.

Article  CAS  PubMed  Google Scholar 

Shiraz P, Payne KJ, Muffly L. The current genomic and molecular landscape of Philadelphia-like acute lymphoblastic leukemia. Int J Mol Sci. 2020;21:2193.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jain S, Abraham A. BCR-ABL1-like B-acute lymphoblastic leukemia/lymphoma: a comprehensive review. Arch Pathol Lab Med. 2020;144:150–5.

Article  CAS  PubMed  Google Scholar 

Ribera JM. Philadelphia chromosome-like acute lymphoblastic leukemia. Still a pending matter. Haematologica. 2021;106:1514–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chiaretti S, Messina M, Della Starza I, Piciocchi A, Cafforio L, Cavalli M, et al. Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913. Haematologica. 2021;106:1559–68.

Article  CAS  PubMed  Google Scholar 

Gupta DG, Varma N, Kumar A, Naseem S, Sachdeva MUS, Binota J, et al. PHi-RACE: PGIMER in-house rapid & cost effective classifier for the detection of BCR-ABL1-like acute lymphoblastic leukaemia in Indian patients. Leuk Lymphoma. 2022;63:633–43.

Article  CAS  PubMed  Google Scholar 

Plotka A, Lewandowski K. BCR/ABL1-like acute lymphoblastic leukemia: from diagnostic approaches to molecularly targeted therapy. Acta Haematol. 2022;145:122–31.

Article  CAS  PubMed  Google Scholar 

Harvey RC, Mullighan CG, Chen IM, Wharton W, Mikhail FM, Carroll AJ, et al. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood. 2010;115:5312–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chiaretti S, Gianfelici V, O’Brien SM, Mullighan CG. Advances in the genetics and therapy of acute lymphoblastic leukemia. Am Soc Clin Oncol Educ Book. 2016;35:e314–22.

Article  PubMed  Google Scholar 

Totadri S, Singh M, Trehan A, Varma N, Bhatia P. Keeping PACE with Ph positive to Ph-like detection in B-lineage acute lymphoblastic leukemia: a practical and cost effective (PACE) approach in a resource constrained setting. Indian J Hematol Blood Transfus. 2018;34:595–601.

Article  PubMed  PubMed Central  Google Scholar 

Sanchez R, Ribera J, Morgades M, Ayala R, Onecha E, Ruiz-Heredia Y, et al. A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics. Blood Cancer J. 2020;10:43.

Article  PubMed  PubMed Central  Google Scholar 

Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature. 2008;453:110–4.

Article  CAS  PubMed  Google Scholar 

Harvey RC, Kang H, Roberts KG, Chen I-ML, Atlas SR, Bedrick EJ, et al. Development and validation of a highly sensitive and specific gene expression classifier to prospectively screen and identify B-precursor acute lymphoblastic leukemia (ALL) patients with a Philadelphia chromosome-like (“Ph-like” or “BCR-ABL1-Like”) signature for therapeutic targeting and clinical intervention. Blood. 2013;122:826.

Article  Google Scholar 

Boer JM, Koenders JE, van der Holt B, Exalto C, Sanders MA, Cornelissen JJ, et al. Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates. Haematologica. 2015;100:e261–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chiaretti S, Brugnoletti F, Messina M, Paoloni F, Fedullo AL, Piciocchi A, et al. CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities. Leuk Res. 2016;41:36–42.

Article  CAS  PubMed  Google Scholar 

Tsaur G, Muhacheva T, Kovalev S, Druy A, Sibiryakov P, Olshanskaya Y, et al. Application of real-time PCR for the detection of BCR-ABL1-like group in pediatric acute lymphoblastic leukemia patients. Blood. 2018;132:1376.

Article  Google Scholar 

Fasan Annette KW, Nadarajah N, Weber S, Schindela S, Schlenther N, Schnittger S, et al. Three steps to the diagnosis of adult Ph-like ALL. Blood. 2015;126:2610.

Article  Google Scholar 

Patkar N, Bhanshe P, Rajpal S, Joshi S, Chaudhary S, Chatterjee G, et al. NARASIMHA: novel assay based on targeted rna sequencing to identify chimeric gene fusions in hematological malignancies. Blood Cancer J 2020;10:50.

Article  PubMed  PubMed Central  Google Scholar 

Virk H, Rana S, Sharma P, Bose PL, Yadav DD, Sachdeva MUS, et al. Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort. Ann Hematol. 2021;100:2031–41.